<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> is a rare <z:e sem="disease" ids="C1302790" disease_type="Disease or Syndrome" abbrv="">congenital malformation syndrome</z:e> characterized by the triad of cutaneous and progressive bony <z:hpo ids='HP_0001159'>syndactyly</z:hpo>, midfacial <z:mpath ids='MPATH_133'>hypoplasia</z:mpath> and <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Two missense mutations of the gene encoding the fibroblast growth factor receptor 2 (FGFR2) have been implicated in most cases </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> detected on prenatal ultrasound </plain></SENT>
<SENT sid="3" pm="."><plain>Postnatal genetic analysis showed, for the first time, that the previously reported P253R mutation of the FGFR2 gene is also prevalent in southeast Europe </plain></SENT>
<SENT sid="4" pm="."><plain>After prenatal sonographic detection of anomalies suggestive of <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e>, parents should be counselled about prognosis and risk of recurrence, and the option of amniocentesis should be offered </plain></SENT>
</text></document>